SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Tularik Inc. (TLRK)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: keokalani'nui who wrote (368)12/2/2002 2:40:39 PM
From: scaram(o)uche   of 598
 
Sounds just like Tularik to me. There are at least *three* advanced projects for metabolic diseases. I just believe that they don't want it known, which molecule just entered clinical testing. But they do want it known that they hit the "2-3 INDs for 2002" objective, set in January.

This is exactly the way I like it. Obesity, lipids, diabetes...... the markets are huge. Even within lipid disorders, I couldn't make a guess at which of two targets might be furthest along.

IMO, they're just forcing competitors to spend money and time to get a feel for the project.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News